In addition, abnormal lipid metabolism in RCC may also be due to abnormal expression of key genes of lipogenesis, such as fatty acid synthase, ATP citrate lyase, sterol regulatory element-binding protein 1, and hydroxy acyl-CoA dehydrogenase alpha subunit (Heravi et al., 2022). The gene discussed is FASN; the disease is renal cell carcinoma.